EcoDrugPlus

Ensembl ID : ENSDLEG00000009836
Gene Symbol: ELANE
1 Cross references
91 Possible Orthologues:

Ensembl ID : ENSDLEG00000015150
Gene Symbol: LOC111162959
1 Cross references
69 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSDLEG00000019151
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSDLEG00000008447
Gene Symbol: HMGCR
3 Cross references
272 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSDLEG00000013652
Gene Symbol: PDPK1
3 Cross references
244 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSDLEG00000008815
Gene Symbol: HPD
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S27-Like

Ensembl ID : ENSDLEG00000016412
Gene Symbol: LOC111162846
2 Cross references
84 Possible Orthologues:

40s Ribosomal Protein S27-Like

Ensembl ID : ENSDLEG00000001130
Gene Symbol: LOC111181263
3 Cross references
82 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSDLEG00000018754
Gene Symbol: NT5E
3 Cross references
250 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSDLEG00000002516
Gene Symbol: HTR1B
1 Cross references
244 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSDLEG00000018894
Gene Symbol: HTR1E
3 Cross references
157 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSDLEG00000011735
Gene Symbol: HTR1F
3 Cross references
146 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).